Heart Failure with Preserved vs. Reduced Ejection Fraction: Patient Characteristics, In-hospital Treatment and Mortality—DanAHF, a Nationwide Prospective Study-Reference-Cited by-同舟云学术

Heart Failure with Preserved vs. Reduced Ejection Fraction: Patient Characteristics, In-hospital Treatment and Mortality—DanAHF, a Nationwide Prospective Study

Published:2023-04-13 Issue: Volume: Page:
ISSN:1937-5387
Container-title:Journal of Cardiovascular Translational Research
language:en
Short-container-title:J. of Cardiovasc. Trans. Res.

Author:

Lassen Maria^ORCID,Seven Ekim,Søholm Helle,Hassager Christian,Møller Jacob Eifer,Køber Nana Valeur,Lindholm Matias Greve

Funder

Novartis

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12265-023-10385-7.pdf

Reference24 articles.

1. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93(9):1137–46.

2. Bleumink GS, Knetsch AM, Sturkenboom MCJM, Straus SMJM, Hofman A, Deckers JW, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure - the Rotterdam Study. Eur Heart J. 2004;25(18):1614–9.

3. Lam CSP, Donal E, Kraigher-Krainer E, Vasan RS. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail. 2011;13(1):18–28.

4. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63(12):1123–33. https://doi.org/10.1016/j.jacc.2013.11.053.

5. Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;03(01):7–11 (Available from: https://www.cfrjournal.com/articles/global-public-health-burden-heart-failure).